|
Jun 17
|
Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
|
|
Dec 28
|
Clover Announces Positive Phase Ⅰ Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)
|
|
Nov 7
|
Clover Completes BLA Submission for Seasonal Influenza Vaccine in Brazil
|